The European Commission has awarded 3.4 Million Euro under the Horizon 2020 programme to a new Marie Curie European Training Network in which Oxford Drug Design is a consortium partner.
Oxford Drug Design is pleased to announce the addition of Prof. David Livermore to our Scientific Advisory Board.
Oxford Drug Design is pleased to announce the appointment of James B. Kahn, M.D. FIDSA, to the company’s Scientific Advisory Board.
Oxford Drug DesignOxford Centre for InnovationNew RoadOxfordOX1 1BY
Phone: +44 (0) 1865 261 468